FindMyKOL
Clinical trialNCT00445809CompletedObservational

Evaluation of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Early and Evolving Acute Kidney Injury

SponsorAbbott RDx CardiometabolicEnrollment355Kidney Failure, Acute
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Some patients who undergo cardiovascular surgery requiring cardiopulmonary bypass will develop a kidney injury following their surgery. The purpose of this study is to take a blood sample from patients before they have this type of surgery and then at nine time points after their surgery to test their plasma for a biomarker called NGAL and compare the NGAL levels to their creatinine levels. We hypothesize that NGAL is an earlier marker for kidney injury than creatinine.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • University of British Columbia

    Vancouver, British Columbia, Canada

United States
  • St. Anthony'S Central Hospital

    Denver, Colorado, United States

  • George Washington University

    Washington D.C., District of Columbia, United States

  • Maine Medical Center

    Portland, Maine, United States

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • St. Peters Healthcare

    Albany, New York, United States

  • New York Methodist

    Brooklyn, New York, United States

  • Cleveland Clinic Foundation

    Cleveland, Ohio, United States

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, United States

  • University of Texas, Houston

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 2007
Primary completion
31 Dec 2008
Completion
30 Apr 2009
Last update posted
4 Aug 2009
Registered enrollment
355
Registry id
NCT00445809

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.